Skip to Main content Skip to Navigation

Bayesian design and conduct of phase II single-arm clinical trials with binary outcomes: A tutorial

Abstract : The aim of phase II single-arm clinical trials of a new drug is to determine whether it has sufficient promising activity to warrant its further development. For the last several years Bayesian statistical methods have been proposed and used. Bayesian approaches are ideal for earlier phase trials as they take into account information that accrues during a trial. Predictive probabilities are then updated and so become more accurate as the trial progresses. Suitable priors can act as pseudo samples, which make small sample clinical trials more informative. Thus patients have better chances to receive better treatments. The goal of this paper is to provide a tutorial for statisticians who use Bayesian methods for the first time or investigators who have some statistical background. In addition, real data from three clinical trials are presented as examples to illustrate how to conduct a Bayesian approach for phase II single-arm clinical trials with binary outcomes.
Complete list of metadatas

Cited literature [14 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02456790
Contributor : Sarah Zohar <>
Submitted on : Tuesday, January 28, 2020 - 9:58:25 AM
Last modification on : Friday, March 27, 2020 - 3:36:28 AM

File

PhaseII_single_arm_HAL.pdf
Files produced by the author(s)

Identifiers

Collections

Citation

Sarah Zohar, Satoshi Teramukai, Yinghui Zhou. Bayesian design and conduct of phase II single-arm clinical trials with binary outcomes: A tutorial. Contemporary Clinical Trials Communications, Elsevier, 2008, 29 (4), pp.608-616. ⟨10.1016/j.cct.2007.11.005⟩. ⟨inserm-02456790⟩

Share

Metrics

Record views

84

Files downloads

211